Fall & winter is a good time to treat spider and varicose veins: book a consultation with Dr. FoxPlan your winter vein treatment

Fox Vein Care Research · Medicare data

Varicose Vein Procedures in Medicare: New York vs the US, 2019 to 2024

New York clinicians performed 19,131 varicose vein closure procedures paid by Original Medicare in 2024, 26.7% more than in 2019, even as Original Medicare Part B enrollment in the state fell 13.2%. That is 124.7 procedures per 10,000 enrollees, against 104.9 nationally, and 97.3% were billed as office procedures.

19,131

procedures by New York clinicians paid by Original Medicare in 2024

Up 26.7% from 15,100 in 2019; US up 11.7%

124.7

procedures per 10,000 Original Medicare Part B enrollees in New York (US 104.9)

New York ranks 10th of 50 states, 2024

97.3%

billed as office procedures in New York

US 95.0%; New York 94.9% in 2019

53.2%

were foam injections in New York, the most common method

US 41.6%; 3.0 times New York’s 2019 count

We counted procedures that close a faulty (refluxing) vein from the inside: radiofrequency or laser ablation, medical adhesive closure, mechanochemical ablation, and injected foam. Wellpoint Federal, Medicare’s contractor for New York, lists all of these billing codes in its varicose vein billing article (A52870). Spider vein injections are not included.

How many procedures, and how fast they grew

Procedures per 10,000 Original Medicare Part B enrollees, New York, 2019 to 2024
201985.4
202074.9
202194.4
202292.1
2023108.2
2024124.7

Source: CMS Medicare Physician & Other Practitioners by Geography and Service; CMS Medicare Monthly Enrollment. Fox Vein Care calculation.

New York’s count rose from 15,100 in 2019 to 19,131 in 2024. Over the same years, the number of New Yorkers in Original Medicare Part B fell from 1,767,193 to 1,534,407 (person-years), while enrollment in Medicare Advantage and other plans grew from 1,511,057 to 2,041,281. Measured per enrollee, the rate rose 46.0% in New York and 31.9% nationally. Both dipped in 2020, the first year of the COVID-19 pandemic.

Vein closure procedures paid by Original Medicare (first vein or foam session), by where the clinician practices. Per 10,000 Original Medicare Part B enrollees (person-years).

YearNY proceduresNY per 10,000NY in officeUS proceduresUS per 10,000US in office
201915,10085.494.9%262,87079.593.2%
202012,91674.996.3%213,20766.194.5%
202115,68794.497.2%243,34778.995.0%
202214,83892.198.1%250,23284.495.1%
202317,015108.298.0%268,29993.795.2%
202419,131124.797.3%293,549104.995.0%

Among the 50 states, New York had the 10th highest rate in 2024. The highest was Arizona, at 260.4 per 10,000.

Where: almost all in the office

In 2024, 97.3% of New York’s procedures were billed as office (non-facility) services, up from 94.9% in 2019. Nationally the office share was 95.0%. The rest were billed from a facility, such as a hospital outpatient department or a surgery center; the facility’s own payment is separate and is not in this data.

Which methods: foam up, laser down

Share of New York procedures by method, 2024
Foam sclerosant injection53.2%
Radiofrequency ablation24.9%
Laser ablation10.4%
Medical adhesive (glue) closure10.2%
Mechanochemical ablation1.3%

Source: CMS Medicare Physician & Other Practitioners by Geography and Service, 2024. Fox Vein Care calculation.

Foam injections in New York rose from 3,425 in 2019 to 10,177 in 2024, and now make up 53.2% of the state’s procedures (41.6% nationally). Laser ablation fell 60.4% in New York and 45.8% nationally. Radiofrequency ablation grew in New York, from 3,866 to 4,759, while it fell nationally, from 104,778 to 86,009.

Procedures by method (share of all procedures in that place and year).

MethodNY 2019NY 2024US 2019US 2024
Foam sclerosant injection3,425 (22.7%)10,177 (53.2%)47,248 (18.0%)122,082 (41.6%)
Radiofrequency ablation3,866 (25.6%)4,759 (24.9%)104,778 (39.9%)86,009 (29.3%)
Laser ablation5,043 (33.4%)1,996 (10.4%)59,213 (22.5%)32,107 (10.9%)
Medical adhesive (glue) closure2,566 (17.0%)1,951 (10.2%)45,608 (17.4%)52,024 (17.7%)
Mechanochemical ablation200 (1.3%)248 (1.3%)6,023 (2.3%)1,327 (0.5%)

Medicare is revaluing the foam codes

In April 2025, a review group of the American Medical Association’s RVS Update Committee flagged the single-vein foam code because its Medicare use was 10,000 or more and had at least doubled from 2018 to 2023. CMS set new work values for the foam, sclerosant injection and mechanochemical ablation codes in its 2027 Physician Fee Schedule final rule, published November 9, 2026 (Federal Register).

What Medicare pays

In 2024, Original Medicare paid New York clinicians $20.8 million for these procedures, including the extra-vein add-on codes, in all settings ($280.3 million nationally). For radiofrequency ablation of the first vein in the office, the average Medicare payment was $918.68 in New York and $823.52 nationally. These amounts are what Medicare paid after the patient’s deductible and coinsurance.

Office (non-facility) services by billing code, 2024. Clinicians: New York clinicians who billed the code in the office. Avg payment: average Medicare payment per service in the office.

CodeMethodBilled forNY servicesNY cliniciansNY avg paymentUS servicesUS avg payment
36465Foam sclerosant injectionOne vein8,526210$1,139.03100,788$999.49
36466Foam sclerosant injectionSeveral veins, one leg1,575119$1,218.3119,957$1,064.84
36475Radiofrequency ablationFirst vein4,417254$918.6878,182$823.52
36476Radiofrequency ablationEach extra vein14627$252.793,505$218.80
36478Laser ablationFirst vein1,931132$866.7828,944$732.74
36479Laser ablationEach extra vein22317$279.113,561$228.43
36482Medical adhesive (glue) closureFirst vein1,91696$1,486.6449,683$1,296.70
36483Medical adhesive (glue) closureEach extra vein638$113.871,396$105.69
36473Mechanochemical ablationFirst vein24813$1,089.161,296$979.90
36474Mechanochemical ablationEach extra vein361$245.58100$221.45

Who is in this data

These figures cover Original Medicare (fee-for-service) only. In 2024, 52.1% of New York’s Medicare enrollees were in Medicare Advantage or other health plans, and their procedures are not in this data, nor are procedures paid by private insurance or Medicaid.

What this means if you have varicose veins

How we built this study

Limits

Sources

Download the data and cite this page

Download the data (CSV): services, clinicians, patients and average Medicare payment by year, code, setting and place (New York and US), 2019 to 2024. Free to reuse with credit under Creative Commons Attribution 4.0.

Suggested citation: Fox Vein Care. “Varicose Vein Procedures in Medicare: New York vs the US, 2019 to 2024.” November 12, 2026. https://foxvein.com/research/varicose-vein-procedures-new-york/

Speak with a specialist

Questions about varicose vein treatment?

Tell us what you’d like to discuss and our team will be in touch.

Prefer to talk? Call (212) 362-3470.

Our research pages describe public data and published policies. They are general information, not medical, legal or insurance advice, and not a substitute for a medical evaluation.

Request Consultation
Close

Book Online